Advertisement

Advertisement

HK:2171 Stock Latest News

CARsgen Grants 4.27 Million Share Options Under Post-IPO Incentive Scheme

Company AnnouncementsCARsgen Grants 4.27 Million Share Options Under Post-IPO Incentive Scheme

CARsgen Shares Added to Southbound Stock Connect, Opening Door to Mainland Investors

PremiumCompany Announcements

CARsgen Shares Added to Southbound Stock Connect, Opening Door to Mainland Investors

1M ago

CARsgen Narrows 2025 Loss as CAR-T Therapy Sales Grow and Costs Fall

PremiumCompany Announcements

CARsgen Narrows 2025 Loss as CAR-T Therapy Sales Grow and Costs Fall

1M ago

CARsgen Schedules Board Meeting to Approve 2025 Annual Results

PremiumCompany Announcements

CARsgen Schedules Board Meeting to Approve 2025 Annual Results

1M ago

CARsgen to Invest RMB370 Million in New CAR T Manufacturing Base in Shanghai

PremiumCompany Announcements

CARsgen to Invest RMB370 Million in New CAR T Manufacturing Base in Shanghai

2M ago

CARsgen Flags Sharp Narrowing of 2025 Losses on CAR-T Commercial Gains

PremiumCompany AnnouncementsCARsgen Flags Sharp Narrowing of 2025 Losses on CAR-T Commercial Gains

2M ago

CARsgen Extends Share Buyback Plan as Major Shareholder Raises Stake

Company Announcements

CARsgen Extends Share Buyback Plan as Major Shareholder Raises Stake

4M ago

CARsgen Therapeutics Presents Promising Results for CT0596 at ASH Congress

Company Announcements

CARsgen Therapeutics Presents Promising Results for CT0596 at ASH Congress

4M ago

CARsgen Therapeutics Updates Share Repurchase Plan and Sees Increased Stake from Key Shareholder

PremiumCompany Announcements

CARsgen Therapeutics Updates Share Repurchase Plan and Sees Increased Stake from Key Shareholder

5M ago

CARsgen Therapeutics Launches Long-Term Study on Gene-Modified T-Cell Therapy

PremiumCompany Announcements

CARsgen Therapeutics Launches Long-Term Study on Gene-Modified T-Cell Therapy

5M ago

CARsgen Presents Promising Results for Satri-cel at ESMO Congress 2025

PremiumCompany Announcements

CARsgen Presents Promising Results for Satri-cel at ESMO Congress 2025

6M ago

CARsgen to Present CT0596 Research at ASH 2025

PremiumCompany Announcements

CARsgen to Present CT0596 Research at ASH 2025

6M ago

CARsgen Therapeutics Announces Board Composition and Roles

PremiumCompany AnnouncementsCARsgen Therapeutics Announces Board Composition and Roles

7M ago

CARsgen Therapeutics Announces Passing of Key Non-Executive Director

Company Announcements

CARsgen Therapeutics Announces Passing of Key Non-Executive Director

7M ago

CARsgen Therapeutics Grants Over 6.7 Million Options to Align Employee Interests

Company Announcements

CARsgen Therapeutics Grants Over 6.7 Million Options to Align Employee Interests

7M ago

CARsgen Presents Updated Results for Zevor-cel at IMS Meeting

PremiumCompany Announcements

CARsgen Presents Updated Results for Zevor-cel at IMS Meeting

7M ago

CARsgen Enhances Governance with New Committee

PremiumCompany Announcements

CARsgen Enhances Governance with New Committee

7M ago

CARsgen Therapeutics Reports Improved Financial Results for H1 2025

PremiumCompany Announcements

CARsgen Therapeutics Reports Improved Financial Results for H1 2025

8M ago

CARsgen Therapeutics to Review Interim Results in Upcoming Board Meeting

PremiumCompany Announcements

CARsgen Therapeutics to Review Interim Results in Upcoming Board Meeting

8M ago

CARsgen Therapeutics Projects Reduced Losses Amid Increased Revenues

PremiumCompany AnnouncementsCARsgen Therapeutics Projects Reduced Losses Amid Increased Revenues

9M ago

CARsgen’s Satri-cel Trial Results Accepted for ESMO 2025

Company Announcements

CARsgen’s Satri-cel Trial Results Accepted for ESMO 2025

9M ago

CARsgen’s Satri-cel NDA Accepted by China’s NMPA

Company Announcements

CARsgen’s Satri-cel NDA Accepted by China’s NMPA

10M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >